Intra-Cellular Therapies Inc. buy Mizuho
Start price
17.02.24
/
50%
€69.30
Target price
17.02.25
€76.07
Performance (%)
-0.43%
Price
09:30
€66.50
Summary
This prediction is currently active. The BUY prediction by Mizuho for Intra-Cellular Therapies Inc. is nearly unchanged. This prediction currently runs until 17.02.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -7.534% | -7.534% |
iShares Core DAX® | -5.630% | -5.765% |
iShares Nasdaq 100 | -8.559% | -13.005% |
iShares Nikkei 225® | -9.576% | -9.058% |
iShares S&P 500 | -6.631% | -7.103% |
Comments by Mizuho for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Mizuho from $76.00 to $82.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Mizuho for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€71.00
21.06.24
21.06.24
€93.48
21.06.25
21.06.25
-6.34%
09:30
09:30
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€90.20
22.04.25
22.04.25
-5.67%
09:30
09:30